1. Home
  2. APTO vs XIN Comparison

APTO vs XIN Comparison

Compare APTO & XIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APTO
  • XIN
  • Stock Information
  • Founded
  • APTO 1986
  • XIN 1997
  • Country
  • APTO Canada
  • XIN China
  • Employees
  • APTO N/A
  • XIN N/A
  • Industry
  • APTO Biotechnology: Biological Products (No Diagnostic Substances)
  • XIN Homebuilding
  • Sector
  • APTO Health Care
  • XIN Consumer Discretionary
  • Exchange
  • APTO Nasdaq
  • XIN Nasdaq
  • Market Cap
  • APTO 6.7M
  • XIN 15.7M
  • IPO Year
  • APTO N/A
  • XIN N/A
  • Fundamental
  • Price
  • APTO $0.36
  • XIN $3.75
  • Analyst Decision
  • APTO Strong Buy
  • XIN
  • Analyst Count
  • APTO 4
  • XIN 0
  • Target Price
  • APTO $9.00
  • XIN N/A
  • AVG Volume (30 Days)
  • APTO 66.5K
  • XIN 379.0K
  • Earning Date
  • APTO 11-07-2024
  • XIN 01-01-0001
  • Dividend Yield
  • APTO N/A
  • XIN N/A
  • EPS Growth
  • APTO N/A
  • XIN N/A
  • EPS
  • APTO N/A
  • XIN N/A
  • Revenue
  • APTO N/A
  • XIN $667,143,185.00
  • Revenue This Year
  • APTO N/A
  • XIN N/A
  • Revenue Next Year
  • APTO N/A
  • XIN N/A
  • P/E Ratio
  • APTO N/A
  • XIN $0.46
  • Revenue Growth
  • APTO N/A
  • XIN N/A
  • 52 Week Low
  • APTO $0.33
  • XIN $1.92
  • 52 Week High
  • APTO $3.32
  • XIN $7.05
  • Technical
  • Relative Strength Index (RSI)
  • APTO 38.81
  • XIN 48.87
  • Support Level
  • APTO $0.35
  • XIN $3.60
  • Resistance Level
  • APTO $0.42
  • XIN $4.30
  • Average True Range (ATR)
  • APTO 0.02
  • XIN 0.71
  • MACD
  • APTO 0.00
  • XIN -0.11
  • Stochastic Oscillator
  • APTO 25.00
  • XIN 4.35

About APTO Aptose Biosciences Inc.

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

About XIN Xinyuan Real Estate Co Ltd

Xinyuan Real Estate Co Ltd operates as a real estate developer and property manager in China. It focuses on developing residential projects, which typically consist of multiple residential buildings that include multi-layer apartment buildings, and others. Its several projects include auxiliary services and amenities such as retail outlets, leisure and health facilities, kindergartens, and schools. It aims to provide comfortable and convenient real estate-related products and services to middle-class consumers.

Share on Social Networks: